| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 12 |
| 1 | FLUOROURACIL | 7 |
| 2 | FLUOROURACIL CREAM, 0.5% | 7 |
| 3 | CAPECITABINE | 5 |
| 4 | DOCETAXEL | 5 |
| 5 | DOCETAXEL ANHYDROUS | 5 |
| 6 | INSULIN | 5 |
| 7 | OXALIPLATIN | 5 |
| 8 | CYCLOPHOSPHAMIDE | 4 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVOLEUCOVORIN INJECTION | 1 | 0.0003 |
| 1 | DEFIBROTIDE SODIUM | 1 | 0.0003 |
| 2 | LEVOLEUCOVORIN | 1 | 0.0003 |
| 3 | BEVACIZUMAB | 12 | 0.0001 |
| 4 | FLUOROURACIL CREAM, 0.5% | 7 | 0.0001 |
| 5 | FLUOROURACIL | 7 | 0.0001 |
| 6 | TEDUGLUTIDE | 1 | 0.0001 |
| 7 | DOCETAXEL | 5 | 0.0001 |
| 8 | DOCETAXEL ANHYDROUS | 5 | 0.0001 |
| 9 | OXALIPLATIN | 5 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 12 | 0.0001 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 4 | 0.0001 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 9 | 0.0000 |
| 4 | Microtubule Inhibitor [EPC] | 5 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 6 | Folate Analog [EPC] | 1 | 0.0000 |
| 7 | Vitamin A [EPC] | 1 | 0.0000 |
| 8 | Methylxanthine [EPC] | 1 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 4 | 0.0000 |